ClinicalTrials.Veeva

Menu

Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease (BNP-CAD)

I

IRCCS Ospedale San Raffaele

Status

Enrolling

Conditions

Stable Chronic Angina
Chronic Coronary Total Occlusion
Coronary Arterial Disease (CAD)
Chronic Coronary Syndrome
NT-pro-BNP

Treatments

Diagnostic Test: BNP

Study type

Observational

Funder types

Other

Identifiers

NCT07013344
BNP-CAD-HSR-2025

Details and patient eligibility

About

This study aim to investigate the association between plasma NT-proBNP levels and the presence, extent and severity of stenosis in patients with suspected coronary artery disease.

Full description

The investigators prospectively measured plasma NT-proBNP levels in consecutive patients referred to the center for elective diagnostic coronary angiography due to symptoms or signs of coronary artery disease over a two- year period. Patients with conditions known to elevate NT-proBNP levels, including heart failure, severe valvular disease, atrial fibrillation, severe chronic kidney disease (eGFR < 30 mL/min), prior coronary artery bypass grafting, or age over 80 years, were excluded.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient referred for elective coronary angiography due to suspected CAD.
  • NT-proBNP measurement during hospitalization

Exclusion criteria

  • heart failure
  • severe valvular disease
  • atrial fibrillation
  • severe chronic kidney disease (eGFR < 30 mL/min)
  • prior coronary artery bypass grafting
  • age over 80 years

Trial contacts and locations

1

Loading...

Central trial contact

Carlo Gaspardone

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems